Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3836 | 1824 | 46.2 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FRA 1 | Author keyword | 20 | 44% | 2% | 34 |
| 2 | JUN | Author keyword | 16 | 22% | 4% | 66 |
| 3 | V JUN | Author keyword | 15 | 73% | 1% | 11 |
| 4 | FRA 2 | Author keyword | 13 | 51% | 1% | 18 |
| 5 | TAM67 | Author keyword | 10 | 73% | 0% | 8 |
| 6 | JUNB | Author keyword | 8 | 22% | 2% | 32 |
| 7 | SIGNAL TRANSDUCT GROWTH CONTROL | Address | 7 | 28% | 1% | 22 |
| 8 | GENES DEV DIS GRP | Address | 4 | 47% | 0% | 7 |
| 9 | V FOS | Author keyword | 4 | 67% | 0% | 4 |
| 10 | MOMORDIN I | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FRA 1 | 20 | 44% | 2% | 34 | Search FRA+1 | Search FRA+1 |
| 2 | JUN | 16 | 22% | 4% | 66 | Search JUN | Search JUN |
| 3 | V JUN | 15 | 73% | 1% | 11 | Search V+JUN | Search V+JUN |
| 4 | FRA 2 | 13 | 51% | 1% | 18 | Search FRA+2 | Search FRA+2 |
| 5 | TAM67 | 10 | 73% | 0% | 8 | Search TAM67 | Search TAM67 |
| 6 | JUNB | 8 | 22% | 2% | 32 | Search JUNB | Search JUNB |
| 7 | V FOS | 4 | 67% | 0% | 4 | Search V+FOS | Search V+FOS |
| 8 | MOMORDIN I | 4 | 75% | 0% | 3 | Search MOMORDIN+I | Search MOMORDIN+I |
| 9 | TRANSCRIPTION FACTOR AP 1 | 3 | 25% | 1% | 12 | Search TRANSCRIPTION+FACTOR+AP+1 | Search TRANSCRIPTION+FACTOR+AP+1 |
| 10 | C JUN GENE | 3 | 57% | 0% | 4 | Search C+JUN+GENE | Search C+JUN+GENE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | V JUN | 60 | 59% | 4% | 66 |
| 2 | TRANSCRIPTION FACTOR AP 1 | 45 | 34% | 6% | 109 |
| 3 | AP 1 | 42 | 16% | 13% | 236 |
| 4 | FOS | 35 | 13% | 13% | 243 |
| 5 | OSTEO SARCOMA VIRUS | 27 | 57% | 2% | 32 |
| 6 | V FOS | 25 | 55% | 2% | 31 |
| 7 | G0 TO G1 TRANSITION | 24 | 56% | 2% | 30 |
| 8 | RAT 1A CELLS | 23 | 79% | 1% | 15 |
| 9 | FOS PROTEINS | 17 | 42% | 2% | 31 |
| 10 | FRA 1 | 14 | 53% | 1% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| AP-1: A double-edged sword in tumorigenesis | 2003 | 945 | 81 | 65% |
| AP-1 as a regulator of cell life and death | 2002 | 1239 | 96 | 52% |
| AP-1 in cell proliferation and survival | 2001 | 945 | 131 | 51% |
| THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION | 1991 | 2936 | 236 | 46% |
| AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise? | 2010 | 142 | 82 | 48% |
| AP-1 in mouse development and tumorigenesis | 2001 | 417 | 125 | 75% |
| The Fos family of transcription factors and their role in tumourigenesis | 2005 | 210 | 92 | 54% |
| Transcription factors control invasion: AP-1 the first among equals | 2007 | 115 | 108 | 45% |
| Deciphering AP-1 function in tumorigenesis - Fra-ternizing on target promoters | 2007 | 57 | 67 | 66% |
| AP-1 a target for cancer prevention | 2007 | 65 | 80 | 54% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SIGNAL TRANSDUCT GROWTH CONTROL | 7 | 28% | 1.2% | 22 |
| 2 | GENES DEV DIS GRP | 4 | 47% | 0.4% | 7 |
| 3 | BIOMOL MED PHARM | 2 | 67% | 0.1% | 2 |
| 4 | WOUND HEALING INJURY | 2 | 67% | 0.1% | 2 |
| 5 | 44 BINNEY ST | 2 | 50% | 0.2% | 3 |
| 6 | BBVA FDN | 2 | 40% | 0.2% | 4 |
| 7 | CANC CELL BIOL PROGRAMME | 2 | 29% | 0.3% | 5 |
| 8 | MEDDANA FARBER CANC CLIN PHARMACOL | 1 | 100% | 0.1% | 2 |
| 9 | F BBVA CANC CELL BIOL PROGRAMME | 1 | 33% | 0.2% | 3 |
| 10 | UNITE VIRUS ONCOGENES | 1 | 16% | 0.3% | 6 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000147400 | IMMEDIATE EARLY GENE//IMMEDIATE EARLY GENES//GEL RETARDATION ELECTROPHORESIS |
| 2 | 0.0000108502 | ATF3//ATF5//ACTIVATING TRANSCRIPTION FACTOR 3 |
| 3 | 0.0000082825 | SERUM RESPONSE FACTOR//MYOCARDIN//SRF |
| 4 | 0.0000080356 | CANCER PREVENTION EFFICACY//INVOLUCRIN EXPRESSION//CELLULAR MOL TOXICOL PROGRAM |
| 5 | 0.0000079868 | JNK//MKK4//JNK3 |
| 6 | 0.0000074255 | MSSP//C MYC PROTEIN//ONCOGENE RESEARCH |
| 7 | 0.0000072527 | ALPHA NAC//NASCENT POLYPEPTIDE ASSOCIATED COMPLEX//FIAT |
| 8 | 0.0000061863 | COILED COIL//COILED COILS//LEUCINE ZIPPERS |
| 9 | 0.0000061204 | ZBP 89//ZNF148//APOPTOSIS EFFECTOR GENES |
| 10 | 0.0000056867 | EGR 1//EARLY GROWTH RESPONSE 1//N N BUTYL HALOPERIDOL IODIDE |